Mukaram, Rowena .
HRN: 21-80-86 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2024
CEFTRIAXONE 1G (VIAL)
03/18/2024
03/25/2024
IVT
2 Gms
OD
UTI In Pregnancy
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes